Oncology & Cancer

Brain tumor drug receives rare disease designations from the FDA

The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational ...

Medical research

New treatment strategy may benefit patients with brain cancer

Gliomas with mutations in what are called the isocitrate dehydrogenase (IDH) genes are the most common brain tumors diagnosed in younger adults aged 18 to 45 years. Patients can benefit from aggressive surgery, along with ...

Oncology & Cancer

Artificial intelligence enhances brain tumour diagnosis

A new machine learning approach classifies a common type of brain tumor into low or high grades with almost 98% accuracy, researchers report in the journal IEEE Access. Scientists in India and Japan, including from Kyoto ...

Oncology & Cancer

Study charts the immune landscape of multiple brain cancers

A Ludwig Cancer Research study has profiled, in a sweeping comparative analysis, the distinct immune landscapes of tumors that arise in the brain, or gliomas, and those that metastasize to the organ from the lungs, breast ...

Oncology & Cancer

Scientists reveal brain tumors impact normally helpful cells

When the brain gets injured, star-shaped brain cells called astrocytes come to the rescue. In the case of glioma—the most common type of primary brain tumor—this protective action comes at a price.

page 1 from 11

Glioma

A glioma is a type of tumor that starts in the brain or spine. It is called a glioma because it arises from glial cells. The most common site of gliomas is the brain.

This text uses material from Wikipedia, licensed under CC BY-SA